FDA issued an EUA for J&J’s Ad26.COV2-S vaccine on Feb. 27, a day after an advisory panel unanimously recommended that the agency authorize the vaccine for adults 18 and over. J&J’s vaccine is the third COVID-19 vaccine to receive authorization in the U.S. so far.
“Literally it’s on trucks as we’re talking,” Gorsky told Today. There are 4 million doses being shipped at this time, with plans to ship a total 20 million by the end of March and 100 million by the end of June.
This article originally ran on Feb. 26, 2021. Updated Feb. 27 with news of the FDA emergency use authorization — and March 1 with J&J CEO Alex Gorsky discussing vaccine distribution.